92N-0297 Prescription Drug Marketing Act of 1987, Drug Amds of 1992
N 1 Vol#: 6
95N-0220 Substances Appoved use in Preparation Meat/Poultry Products
NAL 1 Vol#: 1
SS 1 Supporting Statement Vol#: 1
97N-0242 BIOLOGICAL PRODUCTS; REPORTING OF ERROR & ACCIDENTS MANUFACT
NAL 1 Vol#: 3
SS 1 Supporting Statement Vol#: 3
98N-1042 Proposed Revision of Administrative Practices and Procedures
NFR 2 Vol#: 1
98P-0151 Introduction Of Downed Cattle Into The Food Supply
C 4050 10 signatures Vol#: 127
C 4051 Joyce Bonvillam Vol#: 127
C 4052 Kathy Van Dame Vol#: 127
C 4053 Form letter count 30 Vol#: 128
C 4054 Mrs. Ora Marshall Vol#: 127
C 4055 Mrs. John F. Porter, III Vol#: 127
C 4056 Margery Steinhouse Vol#: 127
C 4057 Pat Joralemon Vol#: 127
C 4058 Dr. & Mrs. Jack M. Cohen Vol#: 127
C 4060 Caroline Kweller Vol#: 127
C 4061 Tami Kutz Robertson Vol#: 127
C 4062 Abuelita Mexican Food Products Vol#: 127
C 4064 Mr. Robert Sanoff Vol#: 127
C 4065 Mary Beth Pepe M.A., C.M.T. Vol#: 127
C 4067 Edward Castellano Vol#: 127
C 4068 Elsie L. Stebbings Vol#: 127
C 4069 Hilda Brennand Vol#: 127
C 4070 Virginia Osborne Vol#: 127
C 4071 Juanita Kemps Vol#: 127
C 4072 Lila Fudalowitz Vol#: 127
C 4074 Ms. Gina Rudy Vol#: 127
C 4076 Ms. Joan M. Pinder Vol#: 127
EMC 1279 Weston Captial Management, LLC Vol#: 127
EMC 1280 Jennifer K. Himes Vol#: 127
EMC 1281 Stephen Barette Vol#: 127
EMC 1282 Gael Murphy Vol#: 127
EMC 1283 Karen Fritsch Vol#: 127
98P-0509 Refrain from Destroying Dietary Supp. Co Publications
C 335 Don Getzman (Costa Rica) Vol#: 5
99D-5424 Health claims for Conventional Foods & Dietary Supplements
LET 1 Daiichi-Shuppan Publishing Co., LTD Vol#: 1
99N-3088 Mktg Exclusivity & Patent Provisions for Certain Antibioitic
CR 1 AstraZeneca Pharmaceuticals Vol#: 1
00F-0792 OLESTRA BE AMENDED REMOVING REQUIREMENT FOR LABEL STATEMENT
C 48 Jennifer B. Ryder, DPM Vol#: 10
00N-1435 Substantial Evidence Effectiveness of New Animal Drugs
NAL 1 Vol#: 1
SS 1 Supporting Statement Vol#: 1
00P-1446 Mylan Nifedipine extented-release tablets 30mg
PAV 1 HFD-1 to Teva Pharmaceuitcals USA Vol#: 1
00P-1554 Exempt pharmacy compounding systems/Class II devices from PM
C 2 McKenna & Cuneo, L.L.P. Vol#: 1
00P-1602 Remove Unapproved Children's Fluoride Supplements from Mkt
01D-0037 Pre-Store leukocyle reduction/Blood components for transfusi
C 2 Wellmont Holtston Valley Medical Center Vol#: 1
01D-0044 Clinical Laboratory Improvement Amendments of 1988
GDL 1 Guideline Vol#: 1
NAD 1 Vol#: 1
01V-0111 Laser Light Show Q-BeamSeries Q-40(RG)(MC),Q-100G,Q-150G
ACK 1 HFA-305 Vol#: 1
VAR 1 All Star Lanes Vol#: 1
01V-0112 Laser Light Show
ACK 1 HFA-305 Vol#: 1
VAR 1 Larry Kasinski Vol#: 1